U.S. patent application number 10/268960 was filed with the patent office on 2003-02-20 for percutaneous device and method for treating urinary stress incontinence in women using a sub-urethral tape.
This patent application is currently assigned to SOFRADIM PRODUCTION. Invention is credited to Scetbon, Victor.
Application Number | 20030036676 10/268960 |
Document ID | / |
Family ID | 26212669 |
Filed Date | 2003-02-20 |
United States Patent
Application |
20030036676 |
Kind Code |
A1 |
Scetbon, Victor |
February 20, 2003 |
Percutaneous device and method for treating urinary stress
incontinence in women using a sub-urethral tape
Abstract
A device for treating urinary stress incontinence in women
includes a flexible and elongate mechanism including a tape for
supporting a urethra and a flat protective sheath enveloping the
tape; and a puncturing needle with an active distal end and a
proximal end connected to a first end of the flexible and elongate
mechanism, wherein the proximal end of the puncturing needle is
connected to a first end of the flexible and elongate mechanism by
an intermediate traction element, a second end of the flexible and
elongate mechanism being free. A method for treating urinary stress
incontinence in a woman suffering from urinary stress incontinence
is also provided including (a) forming an opening in an anterior
vaginal wall; (b) creating, from two small suprapubic incisions
formed in the abdominal wall, a right track and a left track from
the abdominal skin to the opening formed in the anterior vaginal
wall; (c) using a needle and an intermediate traction element to
follow one of the tracks and following the other track with at
least a needle; (d) verifying by cystoscopy that the paths of the
tracks are outside the bladder and the urethra; (e) using a support
tape surrounded by a plastic sheath to follow the tracks by passage
under an inferior surface of the urethra; (f) adjusting a loop
formed by the sheathed tape under the inferior surface of the
urethra; (g) removing the sheath by pulling the sheath toward the
outside of the woman's body through the small suprapubic incisions;
and (h) leaving the tape implanted from the first to the second
incision and around the urethra to support the urethra.
Inventors: |
Scetbon, Victor; (Paris,
FR) |
Correspondence
Address: |
OLIFF & BERRIDGE, PLC
P.O. BOX 19928
ALEXANDRIA
VA
22320
US
|
Assignee: |
SOFRADIM PRODUCTION
SOCIETE ANONYME 116 AVENUE DU FORMANS
TREVOUX
FR
01600
|
Family ID: |
26212669 |
Appl. No.: |
10/268960 |
Filed: |
October 11, 2002 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
10268960 |
Oct 11, 2002 |
|
|
|
09765351 |
Jan 22, 2001 |
|
|
|
6478727 |
|
|
|
|
09765351 |
Jan 22, 2001 |
|
|
|
09489336 |
Jan 21, 2000 |
|
|
|
6406423 |
|
|
|
|
Current U.S.
Class: |
600/30 |
Current CPC
Class: |
A61F 2/0045 20130101;
A61B 2017/06009 20130101; A61B 2017/00805 20130101; A61B 17/0469
20130101 |
Class at
Publication: |
600/30 |
International
Class: |
A61F 002/02 |
Foreign Application Data
Date |
Code |
Application Number |
Oct 5, 2000 |
FR |
0012753 |
Claims
What is claimed is:
1. A device for treating urinary stress incontinence in women,
comprising: a flexible and elongate mechanism comprising a tape for
supporting a urethra and a flat protective sheath enveloping said
tape; and a puncturing needle with an active distal end and a
proximal end connected to a first end of the flexible and elongate
mechanism, wherein the proximal end of the puncturing needle is
connected to a first end of the flexible and elongate mechanism by
an intermediate traction element, a second end of the flexible and
elongate mechanism being free.
2. The device of claim 1, wherein the free second end of the
flexible and elongate mechanism is attached to an extended by an
additional intermediate traction element.
3. The device of claim 1, wherein the tape has a first end and a
second end and wherein the protective sheath completely envelopes
the tape, including said first and second ends of the tape.
4. The device of claim 1, wherein the sheath is capable of being
split into two parts that are separable by sliding them in opposite
directions relative to the tape, and wherein said device comprises
a splinable mechanism between central and adjacent ends of the
sheath.
5. The device of claim 1, wherein the sheath is capable of being
split into two parts that are separable by sliding them in opposite
directions relative to the tape, and wherein said device comprises
a filament arranged roughly at right angles to a longitudinal axis
of the sheath, wherein said filament is configured to cut said
sheath when traction is exerted on said filament.
6. The device of claim 1, wherein the sheath comprises a
fluoropolymer-based heat-shrinkable material.
7. The device of claim 1, wherein the tape comprises a macroporous
knitted material.
8. The device of claim 1, wherein a central region of the tape has
a resorbable hydrophilic film that reduces the risk of adhesion to
or the risk of erosion of the urethra.
9. The device of claim 1, wherein the puncturing needle has a
curved part adjacent to a roughly straight part that ends at the
proximal end of the puncturing needle.
10. The device of claim 1, wherein the intermediate traction
element is a traction lace.
11. The device of claim 9, wherein said device further comprises an
end piece onto which the sheath is heat shrunk and to which the
traction lace attaches.
12. The device of claim 9, wherein the traction lace has a length
roughly equal to the length of the flexible and elongate
mechanism.
13. The device of claim 1, wherein the intermediate traction
element is a tubular traction element.
14. The device of claim 12, wherein the tubular traction element
and the puncturing needle are attached by screwing them
together.
15. The device of claim 12, wherein the tubular traction element
comprises two parts of roughly equal length, placed end to end and
joined together removably.
16. The device of claim 15, wherein said two parts of roughly equal
length are joined together by screwing them together using a
coupling.
17. The device of claim 1, wherein the puncturing needle with an
active distal end and a proximal end connected to a first end of
the flexible and elongate mechanism is the only puncturing needle
present in the device.
18. The device of claim 1, wherein the tape comprises an open knit
made up of two layers formed by two threaded guide bars each, one
full guide and one empty guide, the two threaded guide bars being
movable symmetrically for an open mesh.
19. A method for treating urinary stress incontinence in a woman
suffering from urinary stress incontinence, said method comprising:
(a) forming an opening in an anterior vaginal wall; (b) creating,
from two small suprapubic incisions formed in the abdominal wall, a
right track and a left track from the abdominal skin to the opening
formed in the anterior vaginal wall; (c) using a needle and an
intermediate traction element to follow one of the tracks and
following the other track with at least a needle; (d) verifying by
cystoscopy that the paths of the tracks are outside the bladder and
the urethra; (e) using a support tape surrounded by a plastic
sheath to follow the tracks by passage under an inferior surface of
the urethra; (f) adjusting a loop formed by the sheathed tape under
the inferior surface of the urethra; (g) removing the sheath by
pulling the sheath toward the outside of the woman's body through
the small suprapubic incisions; and (h) leaving the tape implanted
from the first to the second incision and around the urethra to
support the urethra.
20. The method of claim 19, wherein a needle and an intermediate
traction element are used to follow one of the tracks, and a needle
and a second intermediate traction element are used to follow the
other track.
21. The method of claim 19, wherein each track is produced using a
needle inserted through a suprapubic incision and guided along a
posterior surface of a pubis in contact with a finger of a surgeon
and introduced through an opening to a lower rim of the pubis on
the same side as the suprapubic incision through which the needle
was inserted.
22. The method of claim 19, wherein a distal end of the tape is
connected to a proximal end of the intermediate traction element
after verifying by cystoscopy.
23. The method of claim 19, wherein the sheath is cut in a central
region.
24. The method of claim 19, wherein the incision in the anterior
vaginal wall is T or I shaped.
25. The method of claim 19, in which vaginal detachment is
performed.
26. The method of claim 19, in which a urethral probe is inserted
prior to performing a first incision.
Description
BACKGROUND OF THE INVENTION
[0001] 1. Field of Invention
[0002] The present invention relates to the problems of urinary
incontinence in women and more specifically to the problems of
urinary stress incontinence. The invention relates more
particularly to a percutaneous device for treating urinary stress
incontinence in women using a sub-urethral tape.
[0003] 2. Description of Related Art
[0004] These problems are currently treated during surgical
interventions under local, regional or general anesthetic and
consist in implanting a tape in such a way as to support the
urethra without tension.
[0005] Thanks to the regional or local anesthesia, the surgeon can
immediately check that continence has been restored, with the
participation of the patient.
[0006] An intervention such as this is performed using an
appropriate device including special instruments.
[0007] In particular, it is a known practice in treating urinary
incontinence to use a tape that can be implanted under the urethral
canal, and a sheath surrounding the tape, where the sheath is
withdrawn from the tape after the latter has been implanted.
[0008] There is a known device for treating urinary stress
incontinence in women, comprising:
[0009] a flexible and elongate urethra support means comprising a
tape and a protective sheath lying flat and enveloping the tape,
and
[0010] a puncturing needle with an active distal end and a proximal
end connected to a first end of the flexible and elongate urethra
support means.
[0011] Thus, U.S. Pat. No. 5,899,909 discloses a treatment method
and a treatment device for incontinence. The device described,
which allows a tape to be placed under the urethra, comprises two
special needles. These are mounted in turn, by screw fastening, on
a reusable steel insertion tool made of a handle and of a threaded
manipulator rod which allows each of the needles to be manipulated
in turn. Each needle is fixed to one of the ends of the tape-sheath
assembly.
[0012] Each end of the tape-sheath assembly is fixed to a
frustoconical part of one end of the corresponding needle, using a
shrunk or bonded polymer ring.
[0013] The tape is therefore implanted by introducing each of the
needles through a short incision in the anterior vaginal wall,
these incisions being one on each side of the central position of
the urethra.
[0014] The needles implanted in turn using the manipulator rod,
then travel up around the bladder and the pubic bone and reemerge
from the body through incisions made in the abdominal wall in the
suprapubic region.
[0015] The two halves of the sheath which overlap at the middle of
the tape are withdrawn by pulling on the ends that emerge from the
suprapubic incisions.
[0016] A device such as this requires the use of ancillaries of the
insertion handle and rigid intravesical catheter guide types
especially designed for this type of surgical intervention.
[0017] The known surgical intervention also has a disadvantage
insofar as the needles are introduced into the anterior wall of the
vagina to reemerge in the suprapubic region. This bottom-upward
path cannot be controlled precisely for going around the base of
the bladder. Vesical perforations are far from uncommon. They need
to be recognized preoperatively through the use of two cystoscopies
and entail repeating the maneuvers under more difficult
conditions.
[0018] The two accessories (manipulator handle and rigid probe
guide) must therefore be available to the surgical team during each
intervention, having been previously washed, packaged and
sterilized prior to each use. In addition, this lateral passage
with respect to the bladder, with a vaginal point of entry runs the
risk that the point of the needle will injure the iliac vessels in
the retrocrural region. These vascular lesions have been observed
and have led to fatalities.
[0019] Another drawback of the known device lies in the difficulty
of repeating the intervention, using the same device, when
cystoscopy reveals that the sheath-tape assembly has taken the
wrong course. Retreat may prove difficult and tricky for the
sheath, and especially for the bulky needles.
[0020] The sheath-tape assembly has therefore to be cut and the
device can no longer be used to take a different path. It also
carries the risk of no longer being sterile as it may have been
contaminated during these additional maneuvers.
[0021] Thus no percutaneous treatment exists for female urinary
stress incontinence which uses a tape which can lead to the devices
and technique of the present invention.
SUMMARY OF THE INVENTION
[0022] The present invention provides a device for treating urinary
stress incontinence in women comprising a flexible and elongate
mechanism comprising a tape for supporting a urethra and a flat
protective sheath enveloping the tape; and a puncturing needle with
an active distal end and a proximal end connected to a first end of
the flexible and elongate mechanism, wherein the proximal end of
the puncturing needle is connected to a first end of the flexible
and elongate mechanism by an intermediate traction element, a
second end of the flexible and elongate mechanism being free.
[0023] A method for treating urinary stress incontinence in a woman
suffering from urinary stress incontinence is also provided by the
present invention comprising (a) forming an opening in an anterior
vaginal wall; (b) creating, from two small suprapubic incisions
formed in the abdominal wall, a right track and a left track from
the abdominal skin to the opening formed in the anterior vaginal
wall; (c) using a needle and an intermediate traction element to
follow one of the tracks and following the other track with at
least a needle; (d) verifying by cystoscopy that the paths of the
tracks are outside the bladder and the urethra; (e) using a support
tape surrounded by a plastic sheath to follow the tracks by passage
under an inferior surface of the urethra; (f) adjusting a loop
formed by the sheathed tape under the inferior surface of the
urethra; (g) removing the sheath by pulling the sheath toward the
outside of the woman's body through the small suprapubic incisions;
and (h) leaving the tape implanted from the first to the second
incision and around the urethra to support the urethra.
[0024] The object of the present invention is to overcome the
drawbacks of the prior art so as to obtain a different operative
technique which is easier, quicker and safer (as far as the bladder
and vessels are concerned). The risk of vascular lesion is
minimised because of the orientation and the given direction of the
needle from the start of the procedure. The risk of vesical
puncture is small even in the case of previous interventions in
this regard, as is particularly frequent in this type of pathology.
Using the device and operating method of the invention, the
percutaneous route is used to form top-to-bottom tracks using the
needle, i.e., penetrating via abdominal cutaneous mini-incisions to
exit via a previously formed vaginal opening. Detachment of the
vagina allows the index finger of the surgeon to be insinuated up
to the lower rim of the pubis and thus enables the track of the
needle to be precisely directed.
[0025] The device of the invention enables tracks to be made from
top to bottom on both sides of the abdomen and enables the absence
of vesical puncturing to be confirmed by cystoscopy before engaging
the sheath-tape system. The present device makes it possible to
employ the techniques that will be described in detail later on in
this description.
[0026] Another object of the present invention is to produce a
device for treating urinary incontinence which can be reused easily
if it is introduced into the body in a non-optimum path, an
eventuality which, according to the present invention, can occur
only under exceptional circumstances if there is very strong
adhesion between the bladder and the pubis, generally as the result
of earlier interventions.
[0027] According to an embodiment of the invention, the proximal
end of the puncturing needle is connected to the first end of the
flexible means by virtue of an intermediate traction element, the
second end of the flexible means being free or extended by an
additional intermediate traction element.
[0028] According to one embodiment of the device according to the
invention, the protective sheath completely envelopes the tape,
including its first and second ends.
[0029] According to one embodiment of the invention, the sheath can
be split into two parts that can be separated by sliding them in
two opposite directions relative to the tape, the device comprising
a splinable means between the two central and adjacent ends of the
sheath.
[0030] According to another embodiment of the device according to
the invention, the device comprises a filament arranged roughly at
right angles to the longitudinal axis of the sheath, configured to
cut the sheath when traction is exerted on the filament.
[0031] According to one embodiment of the device according to the
invention, the sheath is made of a fluoropolymer-based
heat-shrinkable material.
[0032] According to one embodiment of the device according to the
invention, the tape is formed from a macroporous knitted
material.
[0033] According to one embodiment of the invention, the tape in
its central region has resorbable hydrophilic film reducing the
risk of adhesion to or the risk of erosion of the urethra.
[0034] According to one embodiment of the device according to the
invention, the puncturing needle has a curved part continuously
adjacent to a roughly straight part ending in its proximal end.
[0035] According to one embodiment of the invention, the
intermediate traction element is a traction lace.
[0036] According to one embodiment, the device according to the
invention comprises an end piece onto which the sheath is heat
shrunk and to which the traction lace attaches.
[0037] According to one embodiment according to the invention, the
traction lace has a length roughly equal to the length of the
flexible means.
[0038] According to a preferred embodiment of the device according
to the invention, the intermediate traction element is tubular.
[0039] According to one embodiment of the device according to the
invention, the intermediate traction element and the puncturing
needle are assembled by screwing.
[0040] According to one embodiment of the device according to the
invention, the traction element consists of two parts of roughly
the same length, placed end to end and joined together removably,
for example by screwing, using a coupling.
[0041] According to one embodiment of the device according to the
invention, the puncturing needle with an active distal end and a
proximal end attached to a flexible and elongate means is the only
puncturing needle.
BRIEF DESCRIPTION OF THE DRAWINGS
[0042] Other features and advantages of the invention will become
apparent from the detailed non-limiting description given
hereinafter with reference to the appended drawings, in which:
[0043] FIG. 1 depicts a view in section of the flexible means of
the device according to the invention;
[0044] FIG. 2 depicts a view from above, with partial cutaway, of
the flexible means shown in FIG. 1;
[0045] FIG. 3 depicts, in part, another exemplary embodiment of the
flexible means of FIG. 2;
[0046] FIG. 4 depicts a partial view of a device according to the
invention;
[0047] FIGS. 5 and 6 depict details of FIG. 4;
[0048] FIGS. 7 and 8 depict another embodiment of the flexible
means of the device according to the invention;
[0049] FIG. 9 depicts a partial view of another embodiment of the
device according to the invention;
[0050] FIGS. 10, 11a, 11b and 11c depict details of the device
depicted in FIG. 9;
[0051] FIGS. 12 to 19 diagrammatically depict the surgical method
employed using the device according to the invention; and
[0052] FIGS. 20 and 21 diagrammatically depict the position of the
device according to the invention in the body of a patient.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
[0053] The device depicted in FIGS. 1, 2, 3 and 4 comprises an
elongate flexible means 1 generally comprising a composite
band.
[0054] The flexible means 1 is shown only in part and not in its
entire length. It generally has a flattened and elongate shape.
[0055] The first end 1a of the flexible means 1 can be connected to
an intermediate traction element 2 (cf. FIG. 4) and the second end
1b is free or extended by an additional intermediate traction
element (not depicted).
[0056] The device according to the invention also comprises a
puncturing needle 3, for example made of stainless steel, connected
to the intermediate traction element.
[0057] The flexible means 1 comprises a protective sheath 5 lying
flat and enveloping a tape 6.
[0058] The single puncturing needle 3 has an active distal end 3a
and a proximal end 3b connected to the first end 1a of the flexible
means 1.
[0059] The proximal end 3b of the puncturing needle 3 is connected
to the first end 1a by virtue of an intermediate traction element
2. The proximal end 3b is thus a non-puncturing end. The proximal
end 3b of the puncturing needle may have a substantially
rectangular cross-section and may be flattened and/or ribbed. These
features allow the surgeon to grip the needle and allows the needle
to be oriented correctly.
[0060] The distal end 3a is at the end of a curved part
continuously adjacent to a roughly straight part, approximately
between points 3b and 3d, ending in the proximal end 3b. The distal
end 3a may be partially curved and preferably has a round
cross-section. Distal end 3a may have a diameter of, for example,
0.5 mm. The roughly straight part may be, for example, 20 to 25 cm
in length and may, in embodiments, be ribbed over at least a
portion thereof.
[0061] The puncturing needle has, for example, a diameter of 3.5 mm
in its curved part.
[0062] The proximal end 3b is also equipped with an attachment
means allowing it to make a connection with the intermediate
traction element.
[0063] The intermediate traction element is constituted by a hollow
PVC tube with a diameter that is identical to, or closely similar
in diameter to, that of the needle. The intermediate traction
element or tubing may be approximately 40 to 50 cm long. Its distal
end 19 and proximal end 20 comprise a male screw connecting piece.
This screw connecting piece is integrally fixed to the traction
element by adhesion and/or screwing. The intermediate traction
element may be colored, for example blue, so that it can readily be
located during cystoscopy in the event of a vesical puncture.
[0064] The protective sheath 5 completely envelopes the tape 6,
including its first end 6a and its second end 6b.
[0065] The sheath 5 is made, for example, of a fluoropolymer-based
heat-shrinkable material. The material of which the sheath 5 is
made is chosen so that it is impervious, for example hermetically
sealed, to isolate the tape 6 intended to be implanted in the body
of the patient from contact with the skin and mucosa when following
the implantation paths through the body.
[0066] The sheath 5 may also exhibit properties of low coefficient
of friction. These properties are therefore found both on the
inside and on the outside of the sheath 5, so as, on the one hand,
to ensure good separation from the tape 6 and, on the other hand,
to reduce the friction inside the body of the patient when the
flexible means 1 is being pulled.
[0067] The tape 6 advantageously has a width of between 6 and 14
mm, preferably between 10 and 12 mm and a length of between 30 and
50 cm, preferably around 40 cm.
[0068] The tape 6 is preferably formed from a macroporous knitted
material.
[0069] The macroporous knitted material comprises, for example, an
open knit made of single stranded polypropylene of between 0.12 and
0.16 millimeter thick and made up of two layers formed by two
threaded guide bars each--one full guide and one empty guide--these
two guides being moved symmetrically for open mesh according to the
following chart:
[0070] bar I: 01-12-32
[0071] bar II: 32-21-01.
[0072] The tape 6 is cut to length in the warp direction of the
knit.
[0073] The tape 6, with a width of for example 12 mm, has the
following properties:
[0074] a breaking strength in the warp direction of
105N.+-.20%,
[0075] an elongation at break in the warp direction of
92%.+-.20%
[0076] an elongation of 36% under a force of 20N
[0077] an onset of curling with a force of 6N and an elongation
of
[0078] 15%.
[0079] The expression "curling" is intended to mean the property
whereby the tape 6 rolls up on itself spontaneously about its
longitudinal axis under longitudinal tensile stress.
[0080] The tape 6 has attractive advantages and, in particular, low
emission of particles as it is stretched, and curling which occurs
only under high stress (6N). None of these aforementioned
properties in any way detracts from the porosity of the tape 6.
[0081] Tape 6 can have a resorbable hydrophilic film in its central
portion that reduces the risk of erosion or sclerosis of the
urethra to a minimum. This central zone may be indicated by a
colored marker.
[0082] In a variation, the tape may comprise other biologically
acceptable materials.
[0083] The sheath 5 can preferably be split into two parts 51, 52
that can be separated by sliding them in two opposite directions
with respect to the tape 6.
[0084] For this purpose, the device according to the invention has
a splittable means 15, roughly at the middle of the sheath 5 and
the two ends of which are secured to the corresponding and adjacent
central ends 5c, 5d of the sheath 5.
[0085] The material of the splittable means 15 is chosen from
materials of the thermoplastic type approved for surgical
application.
[0086] The connection between, on the one hand, the central ends
5c, 5d of the two parts 51 and 52 respectively and, on the other
hand, the splittable center 15, may be obtained by any means able
to make the sheath 5 impervious. The same is true of the free end
5b of the sheath 5, which may be plugged and/or sealed.
[0087] The splittable means 15 comprises a flat slit 15a passing
through it from one longitudinal end to the other, for the free
passage of the tape 6.
[0088] The splittable means 15 may be replaced in an embodiment
depicted in figures 7 and 8, by an adhesive sleeve 16a joining the
ends of the two splittable parts 51 and 52 of the sheath 5. This
sleeve may be weakened, for example by a partial broken cut or a
line of weakness in the sheath 5. The adhesive sleeve 16a made of a
flexible material which sticks firmly to the central ends 5c, 5d
and has a precut tab 16b to make the sleeve 16a easier to tear and
therefore make the sheath 5 easier to split into the two parts 51
and 52.
[0089] According to another embodiment of the device according to
the invention, the one-piece sheath 5 incorporates a filament 16c
arranged roughly at right angles to the longitudinal axis of the
sheath 5, configured to cut the sheath 5 when traction is exerted
on the filament 16c. An example such as this is depicted, for
example, in figure 3. The filament 16c may be advantageously in
color so that it can easily be identified.
[0090] The sheath 5 can thus be split in the central zone 1c of the
flexible means 1 so release the tape 6 inside the body of the
patient.
[0091] The intermediate traction element is, according to one
embodiment of the invention, configured, for example, with a
traction lace 2 depicted in FIG. 4.
[0092] The device according to the invention may also comprise an
end piece 4 to which the sheath 5 is attached by heat-shrinking.
The sheath 5, more particularly its first end 5a, may be heat
shrunk in a sealed manner onto the end piece 4.
[0093] As depicted in FIG. 2. the end piece 4 comprises anchoring
notches 4a into which the heat-shrunk material of the sheath 5
engages. The end piece 4 is made, for example, of a piece of
stainless steel or any other rigid material capable of contacting
with intracorporal tissue.
[0094] Advantageously, the flexible means 1 comprises a knotting
eye 4b (cf. FIG. 4) arranged on the outside of the sheath 5.
Knotting eye 4b consists, for example, of a closed loop and may, as
appropriate, have a point 4c intended to pass through and catch on
one end of the traction lace 2 or any other intermediate traction
element.
[0095] The knotting eye 4b may, for example, be made integrally in
the end piece 4. The latter may also have a roughly flattened and
partially frustoconical shape so as to achieve continuity between
the various thicknesses of the traction lace 2 and the flexible
means 1. The latter has a greater width than the traction lace 2.
Thus a certain continuity between the dimensions of the traction
lace 2 and of the flexible means 1 is obtained. The traction lace
may for example be made of a Teflon-coated material.
[0096] FIG. 4 diagrammatically depicts one exemplary embodiment of
the device according to the invention.
[0097] The needle 3 comprises the proximal end 3b onto which the
first end 2a of the traction lace 2 is attached. The latter has,
for example, at each of its ends 2a and 2b, a loop 2c (cf. FIGS. 5
and 6 respectively) obtained by ultrasonic welding, stitching or
any other means.
[0098] One of these loops, 2c, is mounted on the proximal end 3b of
the needle 3 while the other is mounted in the eye 4b.
[0099] During the procedure, it is thus possible to attach the end
2a of the traction lace 2 to the eye 4b either using the point 4c
secured to the eye 4b or simply by running it through the closed
loop that forms the eye 4b.
[0100] The device according to the invention therefore, for
example, has a traction lace 2, the length of which is, for
example, roughly equal to the length of the flexible means 1,
namely a length of between 30 and 60 cm, for example 40 cm. Such
dimensions or lengths of the traction lace 2 make it possible, if
reference is made to the operative procedure, to avoid engaging the
flexible means 1 in the body before being sure that the path taken
by the needle 3 and the traction lace 2 is optimum. The long
available length of traction lace 2 for carrying out the operative
actions described thus makes it possible for another path to be
taken through the body if need be, without having to manipulate the
flexible means 1.
[0101] By way of variation, it is possible to provide the second
end 1b of the flexible means 1 with an additional intermediate
traction element, such as an additional lace like the one
previously described under reference 2.
[0102] An additional traction lace 2 secured to the free end 1b,
which may also have an end piece 4 for this purpose, allows
traction to be exerted in the opposite direction to its
introduction on the flexible means 1, and allows it to back-track
along its path if it is penetrating incorrectly.
[0103] According to another embodiment of the device according to
the invention, depicted for example in FIG. 9, the intermediate
traction element is a tubular element 20. The material of which the
latter is made may be, for example, PVC. Tubular element 20 may be,
for example, 2.5 mm in diameter.
[0104] The tubular element 20 is preferably semirigid, so that it
can be screwed onto a threaded end 3c secured to the proximal end
3b of the needle 3. The other end of the tubular element 20 is
connected, for example by screwing, to the flexible means 1
comprising an end piece 30 secured to the sheath 5, for example by
heat shrinking. The end piece 30 for this purpose has a
complementary threaded part 30a (see FIGS. 7 and 8).
[0105] The flexible means 1, the tubular element 20 and the two
parts 3a, 3b of the puncturing needle 3 may thus be assembled
removably by screw fastening.
[0106] Other known removable means of connection or attachment may
also be suitable in the context of the present invention.
[0107] The tubular element consists for example of a number of
parts of roughly the same length, for example 20 and 41, placed end
to end and joined together removably by screw fastening. This
end-to-end joining is obtained using a coupling 40 depicted in
FIGS. 10, 11a, 11b and 11c.
[0108] The coupling 40 is made up of two elements, namely an
internal connecting mandrel 42 and an external clamping bush
43.
[0109] At one end, the mandrel 42 has a threaded nipple 42b engaged
in the tubular element part 41 and at the other end has a stud 42a
with teeth 42c intended to be engaged in the tubular element part
20 as depicted in FIGS. 11b and 11c. The shape and dimensions of
the teeth 42c tend to oppose separation of the tubular element part
20 from the mandrel 42.
[0110] Each mandrel 42 is associated with a bush 43 engaged on the
tubular element part 41 so as to clamp part of tubular element part
41 between the threaded nipple 42b and bush 43.
[0111] Bush 43 may also be provided on the anterior end with a
tapping 43a which bites by screwing into the material of which the
abutting end of part 20 is made.
[0112] To begin with, one end of part 41 of the tubular element is
screwed onto the nipple 42b. Bush 43 is then attached to this end
of the part 41, with the constituent material trapped between the
screw thread of the nipple 42b and the sleeve 43, the latter also
clamping the rest of the mandrel 42 except for the projecting stud
42a.
[0113] The two tubular element parts 20 and 41 are assembled by
engaging the stud 42a in one end of part 20 (FIG. 11b) and then by
screwing the end of bush 43 onto the exterior periphery of part 20
(FIG. 11c). The turning of bush 43 is depicted diagrammatically by
the arrow R in FIG. 11c. The mechanical connection between the
tubular element part 20 and the coupling 40 is thus improved.
[0114] The device according to the present invention makes it
possible to implement a method for treating women suffering from
urinary stress incontinence. This method will be specified herein
below and allows the tape 6 to be fitted in the patient's body.
[0115] The treatment method comprises:
[0116] a) forming an opening 103a in the anterior vaginal wall
103;
[0117] b) making two small suprapubic incisions 106, 107;
[0118] c) using the puncturing needle 3 connected to an
intermediate traction means 2 or 20 to create a first path
traveling around the pubic bone 105 and emerging in the opening
103a formed in the anterior vaginal wall 103;
[0119] d) using the puncturing needle 3 connected to an
intermediate traction means to create a second path around the
pubic bone 105 and emerging in the opening 103a formed in the
anterior vaginal wall 103;
[0120] e) using cystoscopy to check that the making of these paths
has not punctured the bladder 101 or the urethra 100;
[0121] f) connecting the parts of the device emerging from the
opening 103a formed in the anterior vaginal wall 103;
[0122] g) pulling on the intermediate traction element 2 or 20 to
adjust the loop formed by the flexible means 1 on the underside of
the urethra 100;
[0123] h) separating and withdrawing the two halves of the sheath
5; and
[0124] i) leaving the tape 6 between the first suprapubic incision
106 and the second suprapubic incision 107 passing under the
underside of the urethra 100.
[0125] According to one embodiment of the invention, the method
comprises guiding the paths of the puncturing needle 3 along the
posterior surface 105a of the pubis, by contact with the finger 50
of the surgeon introduced through the opening 103a, formed in the
anterior vaginal wall 103, as far as the lower edge 105b of the
same side of the pubis 105.
[0126] In a variation, a one-piece needle may be used that can
terminate in a male screw connecting piece. Passage of a track on
the right and left side is made by screwing a portion of the
traction element to the proximal end of the needle. Cystoscopy
verifies the absence of punctures; then the two tubular halves are
connected to each other using the small metal part to form a single
traction element disposed in a loop beneath the urethra. The
remainder of the intervention is identical.
[0127] According to one embodiment of the method according to the
invention, the flexible means 1 is attached to the intermediate
element 2 or 20 after the check provided for in step (e) has been
made.
[0128] According to one embodiment of the method according to the
invention, the opening 103a made in the anterior vaginal wall 103
is vertical.
[0129] According to a method of the invention, a urethral probe 60,
for example of the FOLEY balloon type, may be inserted into the
patient beforehand.
[0130] According to one embodiment of the treatment method
according to the invention, use is made of two intermediate
traction elements 2 or 20 connected end to end during step (f).
[0131] According to another embodiment of the treatment method
according to the invention, the puncturing needle 3 and the
intermediate traction element 2 or 20 are separated once the check
according to step (e) has been made and once the flexible means 1
has been introduced along the first path. This separation then
makes it possible to create the second path using the puncturing
needle 3 connected to the intermediate traction element 2 or
20.
[0132] All of the above defined steps are now described with a
device according to FIGS. 7 to 11 and the description relating
thereto.
[0133] The first step (a) is illustrated in FIG. 12. The patient is
placed in a gynecological position and a sterile operating zone is
formed. A urethral balloon probe 60 is positioned in the bladder
101 and is connected to a sterile collecting bag to empty and
flatten the bladder 101. A short vertical incision 103a, at most 30
mm long, is made in the middle of the vaginal wall 103, for example
in a T or I shape, centered in the central third of the urethral
canal 100 opening to the urinary meatus 100a. Each lip 103b of the
vaginal incision 103a is detached from the underlying tissues using
scissors 71 and appropriate instruments 70, as illustrated in FIG.
13.
[0134] Detachment is performed until the surgeon's index finger 50,
introduced through the resulting opening 103a, can reach the lower
edge 105b of the pubis 105, away from the urethra 100 and the
periurethral tissue (FIG. 14).
[0135] Next, a very small cutaneous incision 106, 107 less than 10
mm long is made in the abdominal skin immediately above the pubis
105, on each side of the centerline and about 20 mm away from the
latter, to allow the percutaneous passage of the needle 3 just off
the posterior face 105a of the pubis 30 in the direction of the
vagina 104.
[0136] The surgeon's index finger 50 is introduced into the vaginal
passage thus prepared by detachment, and the active distal end 3a
of the needle 3 follows a path to come into direct contact with
index finger 50. The path of the puncturing needle 3 is therefore
controlled. The needle 3 can then reemerge through the vaginal
opening 103a and the bladder 101 has remained safe from any injury
by the needle.
[0137] In general, the straight percutaneous path is made first.
The end of the intermediate traction element, for example the
tubular element 20, reemerges behind the needle 3 via the vaginal
opening 103a. This end of the traction element 20 is for example
unscrewed from the proximal end 3b of the needle 3 and is detached
from the latter in the direction of the arrow S in FIG. 15.
[0138] The needle 3 is then passed along the second path (on the
left-hand side in FIG. 16) in the same way as for the first side
(right-hand side). Once the distal part 3a of the needle is well
away from the vaginal opening 103a, it can be detached by
unscrewing its proximal portion 3b. This separation is depicted
diagrammatically by the arrow T in FIG. 16.
[0139] The so-called proximal portion 3b is long enough to project
when the percutaneous incision 107 is made.
[0140] By way of an alternative form according to the invention,
the proximal portion 3b may be extended by an additional tubular
element 20 which projects out of the abdominal incision 107.
[0141] The next step consists in connecting the end of the tubular
traction element 20 that follows the first path to the proximal
portion 3b or to the additional tubular element 20 that follows the
second path.
[0142] Connection is made using the coupling 40 depicted in FIG.
17.
[0143] The proximal portion 3b is then led back out through the
abdomen by pulling in the direction of the arrow V illustrated in
FIG. 18.
[0144] Before the flexible means 1 penetrates the patient's body,
the tubular element 20 thus forms a loop around the urethra and its
two ends reemerge respectively through the two abdominal cutaneous
incisions 106 and 107 (FIG. 18).
[0145] The urethral probe 60 may then be removed and cystoscopy is
used to check for the absence of vesical perforation.
[0146] Once the check has been made, the end of the tubular element
20 that emerges from the abdominal incision 106 is assembled by
screw fastening on the threaded end 30a of the flexible means 1
(sheath 5 plus tape 6) and the assembly is pulled (arrow V in FIG.
18) through the right and left paths to position the flexible means
1 under the urethra 100. When this positioning which corresponds to
step (g) is complete, the ends 1a, 1b of the flexible means 1
reemerge from the abdominal incisions 106, 107 as depicted in FIG.
21.
[0147] The sheath 5 may then be separated from the tape 6 by
cutting the sheath 5 in its central zone 1c and withdrawing each of
the halves 51 and 52 thus obtained through the corresponding
abdominal incision 106, 107 according to step (h) (arrows W in FIG.
19).
[0148] The tape 6 may thus be released, positioned and adjusted
under the underside of the urethra 100, usually in a central
position, without tension and without being squashed, as depicted
in FIG. 20.
[0149] Once the sheath 5 has been withdrawn through each abdominal
incision 106 and 107, the parts of the tape 6 which project out of
the incisions 106 and 107 are cut off flush with the abdominal
wall, the parts being left at the subcutaneous site.
[0150] The cutaneous incisions may be closed up using conventional
methods.
[0151] The tape 6 advantageously runs around the pubic bone 105 via
its pelvic or deep face, and heads towards the contralateral
abdominal wall.
[0152] The resulting vaginal incision 103a made in the vaginal wall
103 may then be closed once the definitive position of the tape 6
under the urethra 100 has been checked.
[0153] By way of a variation, the traction lace 2 can also be used
for implementing the method.
[0154] The operating procedure thus used is notable in that it is a
percutaneous operating technique because the dimension of the
abdominal cutaneous incisions is minimal, intended to be just
enough to allow the needles to pass through and because the paths
taken by the needle 3 are downwards, in other words entering
through abdominal incisions 106 and 107 to emerge through the
predetermined and prepared corresponding vaginal opening 103a.
[0155] This presents an enormous advantage from the safety point of
view with respect to the risks of puncturing the bladder 101 on the
one hand, and the iliac vessels on the other hand.
[0156] This is a considerable advantage over the known operating
technique. The path can be checked by cystoscopy.
[0157] When it becomes apparent that the path is not appropriate,
it is possible to withdraw the intermediate traction element 2 or
20 to make a second path through the abdominal cutaneous incision
106, and to do so without introducing the flexible means 1 into the
body.
[0158] All of the elements of the device according to the invention
can thus be reused if the manipulation is incorrect, or if the path
inside the patient's body needs to be improved or optimized. This
represents a considerable advantage over the state of the prior
art.
[0159] Furthermore, the surgical technique described requires
neither the use of an insertion tool for the needle, nor the use of
an endovesical rod to move the bladder 101 and the urethra 100 away
each time the needle 3 passes on a downward path. This constitutes
an advantageous simplification insofar as the surgical technique
put forward in the state of the art entails the use of an
endovesical rod twice, namely after each passage of each of the two
needles which are making an upward path.
[0160] It is to be noted that the device according to the invention
is a percutaneous device, which is advantageous when compared with
the known device which enters via the vaginal mucosa and emerges
through the skin in the abdominal suprapubic region.
[0161] It is notable that the extreme simplicity of the device
according to the invention contributes not only to reducing its
cost price and the number of its constituent parts but also to
increasing the safety for the patient and the quality of the result
when the operating technique described in the present invention is
implemented.
[0162] Checking the effect obtained on continence and adjusting the
tension of the tape 6 are not justified for two main reasons.
Specifically, continence in a lying-down position is not comparable
to the upright position, and the effectiveness of the tape is
explained not by a gripping effect (which carries the risk of
leading to stenosis) but by an effect of providing uplifting
support.
[0163] Furthermore, the operator chooses the position of the tape 6
with respect to the urethral duct 100 according to the clinical
case being studied.
[0164] In the state of the art, this choice cannot be made, and
continence tests are carried out after the bladder has been filled
and coughing stress applied in order to adjust the tension in the
tape, even though the technique is supposedly said to be "tension
free".
* * * * *